AGLVSBBOT• 12 Months (Normalized)
AGL vs BBOT (agilon health inc. vs BridgeBio Oncology Therapeutics Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AGL Performance $84.14
+211.63%
agilon health inc.
Normalized Baseline0.00%
BBOT Performance $3.89
-68.73%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin AGL LEADS
+280.36 pts
AGL outperforming by 280.36 percentage points
AGLBBOT
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AGL BBOT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | AGL Price | AGL Gain (%) | BBOT Price | BBOT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $84.14 | +211.63% | $3.89 | -68.73% | +280.36% |
| Oct 01, 2026 | $82.28 | +204.74% | $- | - | |
| Sep 30, 2026 | $79.59 | +194.78% | $4.10 | -67.04% | +261.82% |
| Sep 29, 2026 | $78.15 | +189.44% | $3.92 | -68.49% | +257.93% |
| Sep 28, 2026 | $79.53 | +194.56% | $3.81 | -69.37% | +263.93% |
| Sep 25, 2026 | $80.73 | +199.00% | $3.95 | -68.25% | +267.25% |
| Sep 24, 2026 | $75.83 | +180.85% | $3.99 | -67.93% | +248.78% |
| Sep 23, 2026 | $84.56 | +213.19% | $4.16 | -66.56% | +279.75% |
| Sep 22, 2026 | $86.84 | +221.63% | $4.66 | -62.54% | +284.17% |
| Sep 21, 2026 | $88.03 | +226.04% | $4.66 | -62.54% | +288.58% |
| Sep 18, 2026 | $89.16 | +230.22% | $4.77 | -61.66% | +291.88% |
| Sep 17, 2026 | $89.17 | +230.26% | $4.89 | -60.69% | +290.95% |
| Sep 16, 2026 | $89.66 | +232.07% | $4.76 | -61.74% | +293.81% |
| Sep 15, 2026 | $92.12 | +241.19% | $4.88 | -60.77% | +301.96% |
| Sep 14, 2026 | $92.38 | +242.15% | $5.05 | -59.41% | +301.56% |
Page 1 of 17